Request Demo
Last update 08 May 2025
Human cord derived MSC cell(Shanghai Aisar Biotechnology)
Last update 08 May 2025
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms IxCell hUC-MSC-O, IxCell hUC-MSC-P, IxCell hUC-MSC-S |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with Human cord derived MSC cell(Shanghai Aisar Biotechnology)NCT06823063
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of a Single Dose of Human Umbilical Cord Mesenchymal Stem Cell Injection (IxCell hUC-MSC-P) in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
NCT05697718
A Phase I Study of Safety and Tolerability of Single-dose Human Umbilical Cord Mesenchymal Stem Cell (IxCell hUC-MSC-S) in Patients With Convalescent Phase of Ischemic Stroke
CTR20223415
一项评价人脐带间充质干细胞注射液（IxCell hUC-MSC-S）在恢复期缺血性脑卒中患者中单次给药的安全性和耐受性的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety and tolerability of a single dose of human umbilical cord mesenchymal stem cell injection (IxCell hUC-MSC-S) in patients recovering from ischemic stroke
100 Clinical Results associated with Human cord derived MSC cell(Shanghai Aisar Biotechnology)
Login to view more data
100 Translational Medicine associated with Human cord derived MSC cell(Shanghai Aisar Biotechnology)
Login to view more data
100 Patents (Medical) associated with Human cord derived MSC cell(Shanghai Aisar Biotechnology)
Login to view more data
100 Deals associated with Human cord derived MSC cell(Shanghai Aisar Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Knee | Phase 3 | China | 05 Jan 2024 | |
| Interstitial lung disease due to connective tissue disease | Phase 1 | China | 26 Jan 2025 | |
| Ischemic stroke | Phase 1 | China | 10 Apr 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free